HIV and the Seroprevalence of SARS-CoV-2
Stout, R. L.; Rigatti, S. J.
Show abstract
ImportanceHealthy HIV-positive insurance applicants have a similar risk of infection and produce a similar antibody response as HIV-negative applicants infected with COVID-19. ObjectiveStudy the seroprevalence and immune response to COVID-19 in healthy HIV-positive life insurance applicants. DesignFrom January 2020 to March 2021, we examined the seroprevalence of COVID-19 in all HIV-positive applicants. Antibody level in 340 age and sex matched COVID-19 positive applicants, 170 HIV-positive and 170 HIV negative, are compared. The data was de-identified of all personal information and separated by month, age and sex. ParticipantsSelf-reported healthy HIV positive life insurance applicants were tested for antibodies to COVID-19.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy 95%
- Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, northern Tanzania 95%
- Evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo Assay for Determining Recent HIV-1 Infection 94%
Similar papers in this journal
- Antibody response in individuals affected with Sars-Cov-2 infection: temporal trends and qualitative and quantitative differences in symptomatic and asymptomatic subjects. A Cross Sectional Analysis. Ab-Covid Study 93%
- Protocol for a qualitative study exploring the experiences and perceptions of dolutegravir/lamivudine dual antiretroviral therapy (the PEDAL Study) in people living with HIV 92%
- Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 – cohort description, test volumes, predictors of viraemia, and the road ahead 92%
Similar papers in this journal
- Trends in diabetes incidence and associated risk factors among people living with HIV in the current treatment era, 2008-2018 94%
- COVID-related Excess Missed HIV Diagnoses in the United States in 2021: Follow-up to 2020 93%
- Accuracy of self-reported HIV testing history and awareness of HIV-positive status among people living with HIV in four Sub-Saharan African countries 93%
Similar papers in this journal
- Assisted partner services for people who inject drugs: Index characteristics associated with untreated HIV in partners 93%
- Outcomes among HIV-positive patients hospitalized with COVID-19 93%
- Mortality among persons with HIV in the United States during the COVID-19 pandemic: a population-level analysis 93%
Similar papers in this journal
- HIV Treatment Outcomes In Rural Georgia Using Telemedicine 95%
- Predictors of Clinical Outcomes among People with HIV and Tuberculosis Symptoms after Rapid Treatment Initiation in Haiti 93%
- Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification among Patients with Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-Income Countries 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.